# EDGAR Filing Document

**Accession Number:** 0001847009
**File Stem:** 0001826470-25-000023
**Filing Date:** 2025-10
**Character Count:** 11115
**Document Hash:** 9f0db463a74705110bf999a372a6319d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001826470-25-000023.hdr.sgml**: 20251017

**ACCESSION NUMBER**: 0001826470-25-000023

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251015

**FILED AS OF DATE**: 20251017

**DATE AS OF CHANGE**: 20251017

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** May Holly
- **CENTRAL INDEX KEY:** 0001847009

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39878
- **FILM NUMBER:** 251401681

**MAIL ADDRESS:**
- **STREET 1:** 6301 FITCH PATH
- **CITY:** NEW ALBANY
- **STATE:** OH
- **ZIP:** 43054
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Petco Health & Wellness Company, Inc.
- **CENTRAL INDEX KEY:** 0001826470
- **STANDARD INDUSTRIAL CLASSIFICATION:** RETAIL-RETAIL STORES, NEC [5990]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 811005932
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0131

**BUSINESS ADDRESS:**
- **STREET 1:** 10850 VIA FRONTERA
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92127
- **BUSINESS PHONE:** 1-858-453-7845

**MAIL ADDRESS:**
- **STREET 1:** 10850 VIA FRONTERA
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92127

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PET Acquisition LLC
- **DATE OF NAME CHANGE:** 20200929

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Petco Acquisition LLC
- **DATE OF NAME CHANGE:** 20200929

## Ex-24

```

                                                                 EXHIBIT 24.1

                                 POWER OF ATTORNEY

	The undersigned hereby constitutes and appoints each of Sabrina Simmons,
Giovanni Insana, Kristen Arn-O'Rourke and Lauren Stigall, and any of their
substitutes, signing singly, as the undersigned's true and lawful
attorney-in-fact to:

1.  obtain credentials (including codes or passwords) enabling the undersigned
to make electronic filings with the U.S. Securities and Exchange Commission
(the "SEC"), including as necessary to prepare, execute in the undersigned's
name and on the undersigned's behalf, and submit to the SEC a Form ID,
including amendments thereto, and any other document necessary or
appropriate to obtain codes or passwords enabling the undersigned to make
electronic filings with the SEC via the Electronic Data Gathering and Retrieval
("EDGAR") system of reports required by the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), the Securities Act of 1933, as amended
(the "Securities Act") or any rule or regulation of the SEC;

2.  act as an account administrator for the undersigned's EDGAR account,
including: (i) appointing, removing and replacing account administrators,
technical administrators, account users, and delegated entities; (ii)
maintaining the security of Filer's EDGAR account, including modification
of access codes; (iii) maintaining, modifying and certifying the accuracy
'of information on the undersigned's EDGAR account dashboard;
and (iv) taking any other actions contemplated by Rule 10 of
Regulation S-T;

3.  execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of Petco Health and Wellness
Company, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section
16(a) of the Exchange Act and the rules thereunder, and Forms 144 in
accordance with Rule 144 under the Securities Act;

4.  do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such
Forms 3, 4 or 5, complete and execute any amendment or amendments thereto,
and timely file such form with the SEC and any stock exchange or similar
authority; and

5.  take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit
to, in the best interest of or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such form
and shall contain such terms and conditions as such attorney-in-fact may
approve in such attorney-in-fact's sole discretion.

	The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing whatsoever
requisite, necessary or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power
of substitution or revocation, hereby ratifying and confirming all
that such attorney-in-fact, or such attorney-in-fact's substitute
or substitutes, shall lawfully do or cause to be done by virtue of
this Power of Attorney and the rights and powers herein granted.
The undersigned acknowledges that the foregoing attorneys-in-fact,
in serving in such capacity at the request of the undersigned,
are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with the requirements
of the Exchange Act or the Securities Act, including Section 16
of the Exchange Act or Rule 144 under the Securities Act.

	This Power of Attorney shall remain in full force and effect until
the earliest to occur of (i) the undersigned is no longer required to file
Forms 3, 4 and 5 and Form 144 with respect to the undersigned's holdings of
and transactions in securities issued by the Company, (ii) revocation by the
undersigned in a signed writing delivered to the foregoing attorneys-in-fact
or (iii) as to any attorney-in-fact individually, until such attorney-in-fact
is no longer employed by the Company and its subsidiaries. This Power of
Attorney revokes all previous powers of attorney with respect to the subject
matter of this Power of Attorney.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 12th day of August 2025.

					 /s/ Holly May
					----------------------------
					Name: Holly May

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>May Holly<br><sub>(Last) (First) (Middle)</sub><br>C/O PETCO HEALTH AND WELLNESS COMPANY,<br>INC., 10850 VIA FRONTERA<br><sub>(Street)</sub><br>SAN DIEGO, CA 92127<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-10-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Human Resources Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Petco Health & Wellness Company, Inc. [ WOOF ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Class A Common Stock | 2025-10-15 |  | F |  | 41811<sup>(1)</sup> | D | $3.55 | 1979577<sup>(2)</sup> | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) The transaction reported reflects the withholding of restricted stock units ("RSUs") in satisfaction of the Reporting Person's tax liability. The RSUs were granted to the Reporting Person on April 15, 2024 pursuant to the Petco Health and Wellness Company, Inc. 2021 Equity Incentive Plan (as amended, the "2021 Plan"), and a portion vested on October 15, 2025.

(2) Includes 1,763,577 outstanding RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of Class A common stock of the Issuer. The number of outstanding RSUs previously reported in footnote 2 of the Reporting Person's Form 4 filed on April 17, 2025 was inadvertently misstated and has been corrected herein.

**Signature:** /s/ Giovanni Insana, as Attorney-in-Fact  
**Date:** 2025-10-17

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**